# An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects

> **NCT06427681** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Zhuhai Beihai Biotech Co., Ltd** · enrollment: 40 (estimated)

## Conditions studied

- Bioavailability

## Interventions

- **DRUG:** BH006 for injection
- **DRUG:** Fosaprepitant for injection+Palonosetron hydrochloride injection

## Key facts

- **NCT ID:** NCT06427681
- **Lead sponsor:** Zhuhai Beihai Biotech Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05
- **Primary completion:** 2024-09
- **Final completion:** 2024-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06427681

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06427681, "An Relative Bioavailability Study of BH006 for Injection in Healthy Subjects". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT06427681. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*